Daily non-political popular news in brief.
Glucosamine-like supplement inhibits multiple sclerosis, type 1 diabetes
05-14-2007 · EurekAlert!A glucosamine-like dietary supplement has been found to suppress the damaging autoimmune response seen in multiple sclerosis and type-1 diabetes mellitus, according to University of California, Irvine health sciences researchers.
Read more »
Keywords: glucosamine-like, supplement, inhibits, multiple, sclerosis, type, diabetes, glucosamine, like, inhibit, sclerosi, diabete
« Previous | Next »
Similar news on "Glucosamine-like supplement inhibits multiple sclerosis, type 1 diabetes":
- Penn researchers discover new molecular path to fight autoimmune diseases
03-06-2007 · EurekAlert!
Multiple sclerosis, diabetes, and arthritis are among a variety of autoimmune diseases that are aggravated when one type of white blood cell, called the immune regulatory cell, malfunctions. In humans, one cause of this malfunction is when a mutation in a gene called FOXP3 disables the immune cells’ ability to function. Penn researchers have discovered how to modify enzymes that act on the FOXP3 protein, in turn making the regulatory immune cells work better.
Similar news · Read more »
- Selenium supplements linked with increased risk for diabetes in 8-year study
07-09-2007 · EurekAlert!
A new analysis of data from a large national study found that people who took a 200 microgram selenium supplement each day for almost eight years had an increased risk of developing type 2 diabetes than those who took a placebo or dummy pill.
Similar news · Read more »
- Immunosuppressive drugs are a double-edged sword to type 1 diabetics
09-04-2007 · EurekAlert!
Type 1 diabetes occurs when immune cells destroy pancreatic insulin producing beta-cells. It was hoped that islet transplantation would provide a cure for the disease, however, transplant success is short-lived and accompanied by significant side effects. New data indicate that the immunosuppressive drugs used to prevent islet transplant rejection suppress beta-cell regeneration in diabetic mice, raising the possibility that identifying immunosuppressive drugs that do not inhibit beta-cell regeneration might lead to successful regenerative islet transplantation.
Similar news · Read more »
- Rutgers scientist's research reveals critical knowledge about the nervous system
11-06-2007 · EurekAlert!
Uncover the neural communication links involved in myelination, the process of protecting a nerve's axon, and it may become possible to reverse the breakdown of the nervous system's electrical transmissions in such disorders as multiple sclerosis, spinal cord injuries and diabetes. With $697,065 in grants from the NJ Commissions on Spinal Cord Injury and Brain Injury Research, Haesun Kim, biology professor at Rutgers, is working on gaining a better understanding of those links.
Similar news · Read more »
- Downstate researchers target multiple sclerosis
11-21-2006 · EurekAlert!
Researchers at SUNY Downstate Medical Center have developed a substance that inhibits the progress of multiple sclerosis in an animal model.
Similar news · Read more »
- Immune responses spread from one protein to another in type 1 diabetes
12-01-2006 · EurekAlert!
Type 1 diabetes (T1D) occurs when the immune system inappropriately attacks cells in the pancreas. Although many of the proteins attacked during T1D have been identified, it has not been determined whether immune responses to the individual proteins develop independently or whether a response to one protein then spreads to others. Now, a new study shows that in mice the immune system first attacks a single protein and then expands its attack to other proteins.
Similar news · Read more »
- Rapid-acting insulin analogues in diabetes mellitus type 1 -- Superiority not proven
07-17-2007 · EurekAlert!
There is currently no evidence available of a superiority of rapid-acting insulin analogues over human insulin in the treatment of adult patients with diabetes mellitus type 1. The evidential value and design of studies available so far are inadequate and do not allow conclusions regarding most patient-relevant therapy goals, such as the reduction in long-term complications or overall mortality. Due to the lack of data, the benefit of rapid-acting insulin analogues in children and adolescents is unclear.
Similar news · Read more »
- Glycemic control medication appears to have favorable effect regarding risk of cardiovascular events
09-11-2007 · EurekAlert!
A meta-analysis of previous research suggests that use of pioglitazone -- a glycemic control medication for patients with type 2 diabetes -- significantly reduces the risk of heart attack, stroke and death, but increases the risk for serious heart failure, according to an article in the Sept. 12 issue of JAMA.
Similar news · Read more »
- Children's Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes
11-09-2007 · EurekAlert!
Researchers at Children's Hospital of Pittsburgh of UPMC are participating in an international clinical trial currently underway to study the effectiveness of oral insulin in preventing or delaying the onset of type 1 diabetes in people at risk for the disease.
Similar news · Read more »
- Carrot cake study on sugar in type 2 diabetes
01-08-2008 · EurekAlert!
Patients with type 2 diabetes are often advised to limit sucrose (table sugar) intake. A new study has shown that patients who increased their daily sugar intake (in the form of carrot cake) but maintained a stable body weight, showed no adverse changes in their condition.
Similar news · Read more »
